Paragonimiasis, a zoonotic disease caused by several species of *Paragonimus*, is a food-borne trematodiasis considered by the World Health Organization (WHO) to be one of the most neglected tropical diseases ([@B32]). *Paragonimus* flukes can infect wild and domestic animals in addition to humans following the ingestion of infective metacercariae found in certain species of freshwater crab and crayfish. Human infections are present in Africa, Asia and the Americas, including United States of America, Mexico, Costa Rica, Guatemala, Honduras, Nicaragua, Panama, Colombia, Peru, Venezuela and Brazil ([@B1]. Ecuador has the highest prevalence of human paragonimiasis in the Americas and the disease is officially considered a public health problem ([@B13]. In 1972, following the analysis of weekly epidemiological reports, the Ministry of Public Health (MSP) made it mandatory to report paragonimiasis as a communicable disease. A 1994 WHO report estimated that 21% of the population was at risk for infection based on an expert opinion on the current prevalence of paragonimiasis in Ecuador ([@B34]. Estimates in 1998 indicated that approximately 500,000 Ecuadorians could be infected ([@B39]; however, official reports from the MSP have estimated an average of 85.5 cases per year ([Fig. 1](#f01){ref-type="fig"}) until 2007. This prevalence is lower than expected, which can be attributed to underreporting because human infections occur in rural and remote tropical areas, where infected patients are poor and health services are lacking. Furthermore, the data available at the MSP are from passive records, whereas we have demonstrated in several studies that performing active searches in communities reveals higher rates of diagnosis ([@B7], 1995).

Fig. 1: the number of human cases registered in 30 years by the Ministry of Public Health. There was a marked increase from 23 cases reported in 1978 to 156 in 1987 and then a gradual decline to nine cases in 2007. The peak counts of 1996 and 2006 are due to active searches in communities by research groups.

*Geographic distribution and prevalence of human infections* - Ecuador is located in the northwestern region of South America and is crossed transversely by the equator line and from north to south by the Andes belt, providing three natural regions: the Pacific coastal area, the Amazon to the east and the Andean region in the centre. The first two regions, which comprise 64% of the country, have tropical and subtropical climates, whereas the higher Andean region is cold with warm inter-Andean valleys ([Fig. 2](#f02){ref-type="fig"}).

Fig. 2: map of Ecuador. The central brown Andes belt marks the Andean region. The Pacific coastal and eastern Amazon regions with tropical climate are in green. The yellow colour corresponds to the foothills of the mountains with subtropical climate. Cases of human paragonimiasis have been reported in all provinces except Galapagos Islands (not showed), Santa Elena (5), Carchi (7), Imbabura (8) and Tungurahua (12). The total country's area is 283,560 km2. According to 2010 census, there is a total population of 14,483,499 of which 7,236,822 live in the coastal region, 6,449,355 in the Andean, 739,814 in the Amazon and the rest in the Galapagos Islands ([@B18]). 1: Esmeraldas; 2: Manabí; 3: Los Ríos; 4: Guayas; 6: El Oro; 9: Pichincha; 10: Santo Domingo de los Tsáchilas; 11: Cotopaxi; 13: Bolívar; 14: Chimborazo; 15: Cañar; 16: Azuay; 17: Loja; 18: Sucumbíos; 19: Napo; 20: Orellana; 21: Pastaza; 22: Morona Santiago; 23: Zamora Chinchipe.

Human paragonimiasis in Ecuador was first described in a patient from the coastal region of Chone-Manabí ([@B17]). Based on reported clinical cases and epidemiological studies, 511 cases had been documented by 1969 from five coastal and two Amazon provinces ([@B27]). From 1972-1976, 316 cases were diagnosed from four coastal provinces ([@B4]). In 1980, Urrutia reported more than 2,000 cases in the Amazonian provinces ([@B34]. Subsequently, foci of infection were identified in the coastal communities of Casacay, Pasaje and Piñas-El Oro, Caluma-Bolívar and Zapallo-Manabí ([@B28], [@B40].

Two active field searches of indigenous Chachi communities in the coastal province of Esmeraldas documented the presence of *Paragonimus* eggs in 7.1% and 30.3% of the sputum samples examined ([@B29], [@B16]). From 1988-1991, the MSP recorded 252 cases from various locations in the above province ([@B36]). In the Amazon Region, 124 cases were identified in indigenous Quichua and Shuar and in communities of colonists located along the banks of Napo River ([@B2]).

Prospective and retrospective studies relying on active and passive searches have identified new foci of transmission. From 1976-1993, 98 cases of pulmonary paragonimiasis were diagnosed in the regional hospital of Latacunga in the province of Cotopaxi. A subsequent active case search between 1992-1993 documented an additional 189 cases from three subtropical cantons: La Maná, Pangua and Sigchos ([@B11]). In the coastal province of Manabí, 146 patients from the three cantons of El Carmen, Chone and Pedernales were treated in the regional hospital of El Carmen from 1983-1993 ([@B7]). According to a clinical review (passive search) of 92 cases admitted to the Eugenio Espejo Hospital in Quito, the patients came from communities in both coastal and Amazonia regions ([@B30]). In subsequent active studies of some of these communities, 216 new cases of pulmonary paragonimiasis were documented ([@B8], [@B9]). According to the presence of human infection, the endemic foci in Ecuador were thus located in rural tropical and subtropical areas in the six Amazonian and five coastal provinces, with extensions to five Andean provinces ([@B2], [@B11]).

The incidence of paragonimiasis from 1978-2007 according to the records of the MSP is provided in [Figs 1](#f01){ref-type="fig"}, [3](#f03){ref-type="fig"}, with the incidence from 1998-2007 shown by region. It is important to note that these data represent only patients diagnosed in MSP clinics and hospitals who sought medical assistance (passive search); cases diagnosed in private clinics and hospitals and active cases that were specifically found in remote areas are not considered. Cases are still being diagnosed in hospitals within the endemic areas, with rare migrant cases observed in referral hospitals in non-endemic areas, such as Quito and Guayaquil. Without an official notification, the MSP stopped the obligatory recording of clinical cases of paragonimiasis in 2007.

Fig. 3: the number of overall cases from 1998-2007 in the three geographical regions as registered by the Ministry of Public Health. There was an annual national average of 53.5 (range 9-190) cases. Based on the size of the population distribution, the highest incidence of cases was in the Amazon Region. In 2006, 166 of the 190 patients came from the province of Sucumbíos.

*Life cycle - The parasite* - Prior to 1971, it was believed that the infectious *Paragonimus* species in Ecuador was *Paragonimus westermani* ([@B31]). However, a different species was described in 1971 when non-encysted metacercariae were observed in crabs from a coastal subtropical area, Caluma-Bolivar ([@B41]). These metacercariae were similar to those described in Peru by [@B24] and in Mexico by [@B25]. In 1979, [@B37] described a new species, *Paragonimus ecuadoriensis,* after having observed ovary and testis morphologies and egg size and shape that varied from those described for *Paragonimus inca*, *Paragonimus mexicanus* and *Paragonimus peruvianus*. Further comparative studies, however, revealed that *P. ecuadoriensis* and *P. peruvianus* were identical to *P. mexicanus* ([@B6], [@B26]) and*P. ecuadoriensis* and *P. peruvianus* are described as part of *P. mexicanus* in subsequent publications ([@B1]). Adult parasites obtained from rats, dogs and cats experimentally infected with metacercariae obtained from *Hypolobocera chilensis* in Nalpe-Manabí exhibited similar morphological and morphometric characteristics to those of *P. mexicanus* ([@B38]. A molecular phylogenetic study conducted by sequencing the cytochrome c oxidase subunit 1 and the second internal transcribed spacer genes revealed that isolated metacercariae from *Hypolobocera aequatorialis* from Concordia-Esmeraldas belonged to *P. mexicanus*. This finding was later confirmed in adult worms obtained from experimentally infected cats ([@B19]. In the Amazon, studies of metacercariae from *Mo- reirocarcinus emarginatus* confirmed the presence of *P. mexicanus.*A recent publication studying *Paragonimus* species from Mexico using morphological and molecular approaches identified three distinct species following comparisons with the DNA sequences from the species found in Ecuador ([@B22]. The authors of the publication therefore suggested resurrecting the name *P. ecuadoriensis* for species in South America. However, further studies using molecular, scanning electron microscopy and morphological techniques are required before accepting this suggestion.

Additionally, a small encysted metacercariae, which was tentatively named *Paragonimus napensis,* was found in the northern Amazon Region ([@B3]). Future molecular taxonomy studies are also needed to clarify the identity of this species.

*First intermediate host* - A study performed in 1984 on the snail*Aroapyrgus colombiensis*captured in the Amazon Region revealed it to be the first intermediate host of *Paragonimus.* A total of 2,350 specimens were microscopically examined using two techniques. The first 1,000 specimens were placed in Petri dishes with water and observed microscopically every 12 h for released rediae and cercariae. The remaining specimens were compressed between two glass plates and then examined microscopically. Rediae and cercariae were observed, indicating an infection rate of 0.042% in the snails ([@B3]) and the rediae exhibited characteristic morphological features of *P. mexicanus*([@B23]). In contrast, none of the *Hemisinus maculatus* molluscs captured in a subtropical region of the province of Bolívar were found to be infected ([@B41]).

*Second intermediate hosts* - On the coast, non-encysted metacercariae found in captured *H. aequatorialis* from Jipijapa in the province of Manabí were initially named *P. ecuadoriensis* ([@B4]). In Caluma within the province of Bolívar, non-encysted metacercariae identified as *P. mexicanus* were isolated from *Strengeria eigenmanni*(after referred as*Pseudotelphusa chilensis*) ([@B41]. Among *H. aequatorialis* specimens collected from 45 different rivers in four cantons of the province of Esmeraldas, 42.6% of the crabs were found to be infected with *P. mexicanus* ([@B36]. In *P. chilensis* (at present referred as *H. chilensis*) captured in Nalpe-Manabí and *H. aequatorialis*collected in Concordia-Esmeraldas, 16.1% and 68.5% specimens, respectively, were found to be harbour *P. mexicanus* ([@B19], [@B38].

In the Amazon, *P. mexicanus* metacercariae were found in 96.1% of the *M. emarginatus* (formerly referred to as *Zilchiopsis ecuadoriensis*) individuals examined. These crabs were caught in the same streams where infected *A. colombiensis* molluscs were found. Conversely, none of the *Trichodactylus faxoni* (formerly referred to as *Trichodactylus maytai*) crabs captured were parasitised ([@B3]).

Metacercariae have been found in various organs of crabs. Among the *Hypolobocera* species examined, *P. mexicanus* metacercariae infested the hepatopancreas in 14.4% ([@B35]). In *H. chilensis* from Nalpe-Manabí, metacercariae also showed a preference for the hepatopancreas ([@B38]). However, although *H. aequatorialis* from Quinindé-Esmeraldas showed a preference for the hepatopancreas, metacercariae were also found in muscle and other organs ([@B36]). The metacercariae in crabs from Caluma-Bolívar were found to prefer the hepatopancreas over muscle ([@B41]). It is unknown whether these locations are associated with the parasite or host intermediate species, as in Asia, where various families of molluscs determine which subspecies of *P. westermani*is present ([@B5]). Crabs, both male and female, were found to be infected without any existing predilection, although a higher infection rate was reported in male crabs from Nalpe-Manabí ([@B38]).

In 2013, the authors (HS, MC and DR) studied 35 *T. faxoni*crabs captured from a small stream in the northern Amazon Region: Nuevo Rocafuerte, in the province of Orellana. Of these 35 crabs, 13 (37.1%) were positive for *P. mexicanus.* However, in the coastal region, none of the 153 *Hypolobocera* spp of crabs captured in areas previously considered to be endemic were found to be parasitised by *P. mexicanus*. Metacercariae that have not yet been identified have also been found (unpublished data). In Ecuador, infected crabs have been found at elevations ranging from 150-2,000 m.

Several patients from both the coast and the Amazon regions reported no clinical history of ingesting raw crab, but did eat crayfish ([@B14]). Freshwater crayfish could also be a secondary host in Ecuador, as documented in other countries ([@B1]). Confirmatory studies on these crustaceans are needed.

*Definitive hosts* - In captured wild mammals from the coastal region, adult *Paragonimus* flukes were recovered from the lungs of a *Nasua nasua* (coati or *tejón*)*,* whereas no flukes were found in examined *Didelphis marsupialis* or *marmosas* ([@B4]). In the Amazon, pulmonary cysts containing adult *Paragonimus*were found in captured *D. marsupialis, Felis pardalis* (ocelot or *tigrillo*), *N. nasua* and *Tayassu pecari* (*pécaris*) ([@B35], [@B3]). Cats experimentally infected with metacercariae from *H. aequatorialis* captured in the coastal provinces of El Oro and Esmeraldas developed lung nodules containing*P. mexicanus* flukes ([@B28], [@B36]. Infection in cats, dogs and *Rattus rattus*, but not in hamsters, was achieved with metacercariae obtained from *H. chilensis* in Nalpe-Manabí ([@B38].

*Human infections - Age and gender* - In Ecuador, paragonimiasis is generally diagnosed in adolescents and young adults, but clinical cases have been documented in individuals ranging from four-67 years of age ([@B8], [@B9]). Among patients treated at hospitals in Latacunga and Guayaquil, most affected individuals ranged from 11-30 years of age ([@B14], [@B11]). In the Chachi indigenous groups from Canandé-Esmeraldas River, most affected individuals were 11-30 years of age ([@B16]). During active field searches, infections were found more frequently in children from six-12 years of age ([@B8]).

Regarding gender, no significant differences have been found. However, variations exist depending on the geographical location of the patients. In the indigenous Quichua and Shuar groups and colonists in the Amazon Region, alongside Napo River, women exhibited infection rates of 51.2% ([@B2]) and 52.8% ([@B9]), respectively. In patients treated in hospitals of Latacunga-Cotopaxi and Quito-Pichincha (non-endemic areas), males exhibited infection rates of 52% and 57.7%, respectively. Of the 45 patients admitted to the hospital in the coastal city of Guayaquil, there were 21 males and 24 females ([@B14]). The greatest gender differences were observed in patients treated in a coastal regional hospital in El Carmen-Manabí and those of the indigenous Chachi (province of Esmeraldas), where the infection rates of females reached 66.4% and 90%, respectively ([@B7], [@B16]). The variation in age and gender ratio of infection depends not only on the specific locality and geographical region, but also on the local customs and habits related to the preparation of crustaceans.

*Clinical forms* - Based on all publications, reports, clinical records and available studies, 3,822 cases were documented in Ecuador since 1921, of which 99.7% were pulmonary infections. There were 12 cases of cutaneous paragonimiasis in the same family, presenting signs of migratory inflammation, localised pain and the presence of adult worms confirmed using histopathology ([@B12]). A hepatic form of the disease presented with a tumour lesion in the left lobe of the liver ([@B30]).

The pulmonary symptoms included a productive cough with rust-coloured sputum in 70-100% of the cases, followed by chest pain in 80%. Symptoms were periodic and mild in patients with a short clinical evolution and/or low egg counts in their sputum ([@B30], [@B7]). Most patients showed good general health and nutritional status. However, in the indigenous ethnic group Chachi of Canandé-Esmeraldas River, weight loss and diaphoresis were documented in 60% of cases with a 30% prevalence of fever ([@B16]). Complicated cases involving pleural effusion, exudative pleuritis and emphysaema were reported in 19% of patients referred to the Eugenio Espejo Hospital in Quito ([@B30]). Among 124 patients in the hospital of Nuevo Rocafuerte in the Amazon Region, 12.5% presented with fever and dyspnoea and were in poor health ([@B2]). The duration of disease ranged from three months to 12 years one case lasted 14 years before a diagnosis was made ([@B30]).

*Eating habits in relation to paragonimiasis* - Indigenous groups in Ecuador and migrants to tropical regions practice hunting and fishing, including freshwater crayfish and crabs, for their basic food supply. Certain beliefs and practices are likely to increase infection rates, such as the idea that eating raw crabs is beneficial for hangovers and freshly prepared juice from raw crabs (made from internal organs) is used as a traditional medicine to treat fevers ([@B36]). Certain Amazon communities prepare the "juice" of raw crabs to increase breast milk production in nursing mothers. It is customary for families or groups of neighbours to fish the rivers for crabs and crayfish and then consume them in soup, fried, baked or raw. Children play and fish in the rivers during their free time and eat baked, fried or raw crabs and crayfish ([@B14]). In endemic areas, 94% of patients reported eating crabs and 99% reported eating crayfish ([@B7]). As these eating habits involve the entire family, several members of the same family can become infected, as observed in Chachi ([@B29]), in the Amazon (Amunárriz 1991b) and among coastal settlers ([@B9]).

*Diagnosis* - In Ecuador, a case of pulmonary paragonimiasis is defined as a person presenting with a productive cough with rusty-brown or blood-stained sputum, accompanied by a history of eating raw or improperly cooked freshwater crabs or crayfish and the presence of the characteristic ova of *Paragonimus* in sputum and/or stool samples ([@B13]). The diagnostic method recommended and utilised is the microscopic observation of eggs in sputum and faeces. No concentration methods are used and no serological and/or molecular methods are available. Eggs of *Paragonimus* in sputum have been identified following Ziehl Neelsen staining ([@B9]). The detection of eggs in faecal material can reach up to 13.6%, especially in children because of their habit of swallowing sputum ([@B14]). Faecal detection can also occur during intestinal paragonimiasis, a disease that is undiagnosed in Ecuador and rarely occur worldwide ([@B21]). More than 50% of hospitalised patients showed hypereosinophilia or leucocytosis (11,000-15,000/µL) with normal haemoglobin and haematocrit levels ([@B30]). Microscopy is specific, but the sensitivity depends on the amount and frequency of expectoration, which is inconsistent in patients with mild and moderate disease. Using soluble antigens obtained from adult *Paragonimus*, elevated levels of IgG and IgM were found in patients with pulmonary paragonimiasis according to the presence of eggs in sputum, with the subclass IgG4 antibody being the most dominant ([@B15], [@B16]). In 43 patients, the levels of IgG and IgE determined by ELISA and indirect haemagglutination remained elevated after six months of being treated with praziquantel (PZQ) ([@B20]). These tests were performed only for research purposes.

Crude antigens of *P. westermani* and *Paragonimus heterotremus* were used to test for dermal delayed hypersensitivity in residents of endemic areas, with reactive cases found in children and adolescents ([@B28]); however, the test was discontinued because of severe sensitivity reactions and low specificity ([@B13]). Immunoblot assays were performed using antigens of *P. heterotremus*, with four of seven children who presented with chronic cough, but were negative for eggs in their sputum exhibiting positive results ([@B38]). Studies using crude antigens from various species carry the risk of false negative results.

*Imaging studies* - Radiological imaging was performed only on referred hospitalised patients from rural health centres because of the unavailability of diagnostic methods and/or drugs or because of disease severity. In patients referred to the Eugenio Espejo Hospital in Quito, the most common radiological finding was diffuse and nodular infiltrates (54%), with 11% presenting pleurisy, emphysaema and pleural effusion and 11% presenting normal radiographs ([@B30]). Of the patients treated at hospitals in Nuevo Rocafuerte-Orellana and in Guayaquil, 77% and 85.2% exhibited normal radiological imaging ([@B14], [@B2]). In the former hospital, 13% showed exudative pleuritis, hilar lymphadenopathy and caverns ([@B2]). In patients identified during active searches, 46% presented with diffuse and nodular infiltrates, whereas 39% did not exhibit any radiographic abnormalities ([@B8], [@B9]). Infiltrative images were found to resolve after treatment, but no radiological changes were noted in patients with nodular lesions, pleural effusion or cavities ([@B8]). There were no pathognomonic radiological lesions associated with paragonimiasis. No reports are available using computed tomography or magnetic resonance imaging studies.

*Differential diagnosis and association with tuberculosis (TB) and/or pulmonary mycosis* - Overall, 10.8% of the referred patients treated at the Eugenio Espejo Hospital presented with pulmonary TB ([@B30]), whereas only one (1.5%) patient with TB was found in the hospital of Nuevo Rocafuerte-Orellana (Amunárriz 1991a). No association was found in patients referred to hospitals in El Carmen-Manabí and Francisco de Orellana ([@B35], [@B7]). During active search studies in La Maná-Cotopaxi communities, 12.9% of patients had or were in treatment for pulmonary TB.

Patients with pulmonary paragonimiasis generally exhibited good health and nutritional status. Episodes of cough were periodic and rust-coloured sputum with haemoptysis, as in TB, rarely occurred ([@B9]). None of the cases were associated with pulmonary mycoses despite the fact that paracoccidioidomycosis is endemic in these tropical regions ([@B33]).

*Treatment*- According to the Manual for Paragonimiasis Control in Ecuador, issued in 1991 by the MSP ([@B13]) and by the [@B39], PZQ is the drug of choice for treating pulmonary paragonimiasis. The recommended dosage for treating paragonimiasis is three administrations totalling 75 mg/kg/day for two days. The treatment of patients from the coast and Amazon regions with PZQ was effective in 95-100% of cases, with minimal and transient adverse effects ([@B8]). A 100% cure rate was observed in patients treated with PZQ at 50 mg/kg/day for three days ([@B14]). In the 1970s and 1980s, treatment with bithionol was effective in 80% of patients, but treatment abandonment was common due to severe adverse effects, especially gastrointestinal. Bithionol was effective in treating 62 of 64 patients at the Amazon regional hospital of Nuevo Rocafuerte, with tolerable/manageable adverse effects under an inpatient regimen [@B2] A combination of emetine plus chloroquine was effective in only 18.2% of patients treated ([@B30]). Currently, there are no official guidelines in Ecuador, which has led to a lack of medical knowledge regarding current management and recommended therapy.

In two clinical-therapeutic trials, 216 patients with pulmonary paragonimiasis from the coast and Amazon were treated using triclabendazole (TCB). An efficacy of 100% was obtained, even in patients resistant to PZQ ([@B10]). Using three distinct dose regimens: 5 mg/kg once per day for three days, a single dose of 10 mg/kg or two doses of 10 mg/kg during a single day, all 62 patients were cured, both clinically and parasitologically. In a second study, 154 patients were treated with either 10 mg/kg twice a day or a single dose of 10 mg/kg, with efficacies of 90.9% and 84.4%, respectively, and all patients were cured following retreatment ([@B9]). TCB is now recommended as the alternative drug of choice for treating paragonimiasis and the first drug of choice for fascioliasis ([@B39]). Currently, PZQ and TCB are not available in Ecuador despite their recommendation in the 2013 national therapeutic manual.

*Prevention and control measures* - At present, there are no strategies for diagnosis, updated patient management or preventive measures in Ecuador. A national control or elimination programme of the disease is non-existent.

*Concluding remarks* - Paragonimiasis is endemic to tropical and subtropical regions of Ecuador. Although the disease is known to be present in several locations, epidaemiological studies remain incomplete. Furthermore, the lack of recent active field search and nationwide seroepidemiological studies prevent making an estimate of the current infected population. Knowledge of the intermediate hosts and reservoirs is limited and there is no comparative molecular characterisation of the parasites. To identify possible new species in the Amazon, DNA identification methods are needed. In addition, investigations are recommended to determine the impact that ecological and environmental changes, such as farming, chemical application in oil palm and banana plantations, dam construction and deforestation with the disappearance of animal reservoirs and intermediate hosts, may have on the disease. Preventive programmes to educate and implement changes in the eating habits of residents (only eating well-cooked crabs or crayfish) are of the utmost importance. A continued health education programme for professional personnel, together with ensuring the availability of medication for treatment, is necessary to care for those affected by *Paragonimus*. The lack of drugs recommended for treatment is of great concern because it causes patients to remain infected, with epidaemiological consequences, complications and suffering. The MSP should acquire the drugs and then make them readily available in the health centres of endemic areas.
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